Plus Therapeutics (PSTV) Competitors

Plus Therapeutics (NASDAQ:PSTV) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation.

Do analysts rate PSTV or RCEL?

Plus Therapeutics presently has a consensus price target of $10.83, indicating a potential upside of 1,382.39%. Avita Medical has a consensus price target of $12.40, indicating a potential upside of 124.64%. Given Plus Therapeutics' stronger consensus rating and higher possible upside, research analysts clearly believe Plus Therapeutics is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Plus Therapeutics	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
Avita Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Which has more volatility and risk, PSTV or RCEL?

Plus Therapeutics has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Comparatively, Avita Medical has a beta of 1.63, suggesting that its share price is 63% more volatile than the S&P 500.

Is PSTV or RCEL more profitable?

Avita Medical has a net margin of -68.87% compared to Plus Therapeutics' net margin of -520.90%. Plus Therapeutics' return on equity of 0.00% beat Avita Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Plus Therapeutics	-520.90%	N/A	-202.73%
Avita Medical	-68.87%	-1,272.91%	-71.52%

Does the media prefer PSTV or RCEL?

In the previous week, Avita Medical had 17 more articles in the media than Plus Therapeutics. MarketBeat recorded 20 mentions for Avita Medical and 3 mentions for Plus Therapeutics. Plus Therapeutics' average media sentiment score of 0.93 beat Avita Medical's score of 0.01 indicating that Plus Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Plus Therapeutics	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avita Medical	4 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has higher valuation & earnings, PSTV or RCEL?

Plus Therapeutics has higher earnings, but lower revenue than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Plus Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Plus Therapeutics	$5.82M	7.60	-$12.98M	-$2.94	-0.25
Avita Medical	$64.25M	2.29	-$61.85M	-$1.97	-2.80

Do institutionals & insiders have more ownership in PSTV or RCEL?

3.3% of Plus Therapeutics shares are owned by institutional investors. Comparatively, 27.7% of Avita Medical shares are owned by institutional investors. 0.8% of Plus Therapeutics shares are owned by company insiders. Comparatively, 2.8% of Avita Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Avita Medical beats Plus Therapeutics on 9 of the 16 factors compared between the two stocks.